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Harm or Beneﬁt?*Mauro Moscucci, MD, MBASEE PAGE 1119S ince the initial publication of a landmark News-day article (1) on mortality statistics for coro-nary artery bypass graft surgery (CABG) by
surgeon and by hospital in New York State, public
reporting of outcomes data for CABG and for percuta-
neous coronary intervention (PCI) has been adopted
by other states, and it has become a mainstay of per-
formance assessment in health care. Supporters of
public reporting have advocated that it promotes
accountability and it fosters a drive toward quality
improvement efforts. In addition, by offering infor-
mation to patients on best practices and best out-
comes, it provides the opportunity for informed
decisions regarding where to go for health care. Un-
fortunately, several studies have raised concerns
that physicians’ perception of limitations of risk
adjustment to appropriately account for patients’
risk and the fear of public reporting might lead to
denial of care to high-risk patients (2–5) and, in
some cases, to outmigration of patients to states
without public reporting (6). Other studies have
shown that referral patterns and consumer choices
are not generally affected by available statistics
(5,7). In addition, random variation can have a
signiﬁcant inﬂuence on hospital rankings, and it
should be taken into account when interpreting
data. Finally, the knowledge of variables included
in risk-adjustment models can lead to attempts
toward gaming the system (i.e., knowing that a spe-
ciﬁc variable is associated with an increased risk of*Editorials published in the Journal of the American College of Cardiology
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Williams & Wilkins.mortality might lead to dishonestly over-coding for
that particular variable). From a patient care perspec-
tive, the issue of denying care to the patients who
might need it most remains the most compelling
concern. Thus, the debate surrounding public report-
ing has continued incessantly over the past 2 decades.In this issue of the Journal, Waldo et al. (8) evalu-
ated the association among public reporting, perfor-
mance of PCI, and outcomes of patients presenting
with acute myocardial infarction (AMI). The study
population included patients from the Nationwide
Inpatient Sample with a primary discharge diagnosis
of AMI between 2005 and 2011. States with public
reporting (Massachusetts and New York) were
compared with regional comparable nonreporting
states (Connecticut, Maine, Maryland, New Hamp-
shire, Rhode Island, and Vermont). After multivariable
adjustment, PCI rates were signiﬁcantly lower in
public reporting states compared with nonreporting
states. In addition, lower PCI rates were observed in
elderly patients and in patients presenting with
STEMI, cardiac arrest, and cardiogenic shock in states
with public reporting when compared with non-
reporting states. The lower PCI rates in public report-
ing states were associated with a higher risk-adjusted
in-hospital mortality, which was driven by a higher
mortality in patients not undergoing PCI. Further
breakdown of risk-adjusted mortality rates revealed
important signiﬁcant trends that deserve further
comment. Although in-hospital mortality was higher
in patients not undergoing PCI in public reporting
states, a potential survival beneﬁt was observed for
patients undergoing PCI in public reporting states
when compared with nonreporting states.
There are several possible explanations for
these ﬁndings. First, better coding (and potentially
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1128gaming) for comorbidities associated with a higher
risk of in-hospital mortality following PCI could
account for better risk-adjusted outcomes for the PCI
population in public reporting states. Second, limi-
tations inherent to risk adjustment and the inability
to assess high-risk patients might result in an overall
underestimation of the impact of high-risk patients
who are denied care in public reporting states, but
are still managed with PCI in nonreporting states.
A third possibility is that public reporting actually
provides a drive toward quality improvement for PCI
care, which results in lower mortality in PCI pa-
tients. However, the overall mortality rate is higher
in public reporting states when PCI and non-PCI
patients are merged together, because the beneﬁt
in PCI patients is offset and, in the end, super-
seded by the higher mortality secondary to denial of
care in the overall patients’ population. A futility
assessment in public reporting states leading to
identiﬁcation and exclusion from PCI of patients
unlikely to beneﬁt from PCI might also play a role,
by shifting patients with a high likelihood of death
in the hospital from the PCI group to the non-PCI
group.
The present study conﬁrms prior ﬁndings suggest-
ing a tendency toward risk avoidance and denial of
care in public reporting states, and it expands our
knowledge by including in the analysis both Medicare
and non-Medicare patient populations. Most impor-
tantly, it provides a new critical and disturbing insight
into potential adverse consequences of such risk
avoidance on clinical outcomes. The superiority of
PCI when compared with thrombolysis or con-
servative medical therapy in improving survival of
patients with AMI has been shown in numerous clin-
ical trials, and as of today, when available, primary
PCI is considered the standard of care for this patient
population. Thus, it is troubling to face the possibility
that public reporting of outcome data for PCI might, in
fact, be associated with the unintended consequence
of lower PCI rates in this patient population and in
what could be potentially considered a deviation from
the standard of care, resulting in worse outcomes.
Taking all of this into account, what are the
options? There is no question that collection of
outcome data can foster successful quality improve-
ment efforts, and it can identify “statistically signiﬁ-
cant” variations in outcomes that might require
external interventions or at least an explanation.
Thus, the answer is not to avoid participation in
national or regional registries that provide valu-
able benchmarks and comparative data. Rather, we
should continue to reﬁne our risk adjustmentmethodologies, educate the public on how to inter-
pret available data, and continue to engage the
interventional cardiology community in regional or
national continuous quality assurance and quality
improvement programs.
A complementary approach can be derived from
current policies surrounding public reporting of core
measures. Cardiogenic shock and cardiac arrest are
considered acceptable nonsystem causes of delays
for performing timely PCI in patients with AMI, and
therefore, patients with cardiogenic shock and car-
diac arrest can be excluded from the Core Measures
related to door-to-balloon time when delays due to
stabilization of the patient (e.g., deﬁbrillation or
intubation) occur. It has been advocated that the
same approach should be applied to public reporting
of PCI outcome data (9,10), and both the New York
and Massachusetts Health Departments seem to be
moving in that direction. Following the initial com-
parison of Michigan and New York data that sug-
gested an association between public reporting and
risk aversion in New York, which has led to lower
rates of PCI in high-risk patients when compared
with Michigan (2), a nonreporting state, New York
has chosen the approach of reporting mortality sta-
tistics for PCI in 3 reports. The ﬁrst report includes
all PCI cases, the second report includes elective
cases only, and the third report includes emergency
cases only (11). Although this method provides data
on more homogenous patient populations, it ne-
glects to address the main concern related to public
reporting for high-risk patients. Massachusetts has
approached the process in a slightly different way. In
2009, a new category deﬁned “as exceptional risk”
was developed. Data on exceptional risk admissions
are collected, adjudicated, and analyzed, but they
are eliminated from the models and not reported to
the public; data on elective PCI and PCI for STEMI
and cardiogenic shock are reported separately (12).
Whether the use of the combined interventions
described earlier will result in the “intended” con-
sequence of reducing risk aversion and denial of
care remains to be determined. The hope is that
further expansion of the dataset used by Waldo
et al. (8) and time trend analysis of these data and
other registries will help in answering these new
questions.
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